[Pegfilgrastim vs filgrastim in primary prophylaxis of febrile neutropenia in patients with breast cancer after chemotherapy: a cost-effectiveness analysis for Germany].

Source:http://linkedlifedata.com/resource/pubmed/id/20180162

Download in:

View as

General Info

PMID
20180162